– As Novartis launches Uperio
Eminent cardiologists amongst whom where Emeritus professor, Oladipo Akinkugbe; Prof. Amam Mbakwem, Prof. Michael Balogun, Prof. Waleed Al-Habeeb and Prof. Godfred Achilihu have called for a paradigm shift in the prevention and treatment of heart conditions, saying that a change of strategy is now necessary to reduce the incidence of heart failure.
The experts who spoke during the launch of Uperio-a new drug for the treatment of heart failure by Novartis, at a colourful ceremony held at Intercontinental Hotel, Victoria Island, Lagos, recently, said all those involved in the treatment of heart conditions need to embrace change to get better result.
Prof. Akinkugbe who chaired the event in his opening remarks while noting the importance of adopting new strategies to reduce the incidence of heart failure commended Novartis for organsing the event. Novartis, he said, is one of the very few pharmaceutical companies that has been consistently committed to supporting discourse on health education and dissemination of health information. He urged the company to continue in that stead.
Prof. Balogun who spoke on the topic Heart Failure – Yesterday, Today and the Future, noted that while it may be difficult for physicians managing heart failure and patients to embrace change in the treatment, doing so will make a lot of difference to the life of the patients.
Prof. Balogun said while there was ample evidence that heart failure had existed for a very long time, the condition is now very deadly, adding that it is even deadlier than many cancers. “I believe in the management of heart failure, it is time to embrace change,” he said.
Prof. Mbakwem, who spoke on the topic: Activating Heart Failure Networks – Role of Cardiologists/GP/Pharmacits/Nurses also noted thatparadigm shift is now necessary saying “experts are not winning the battle against heart failure.”
She stressed that there was a need for more systematic coordination of heart failure care and more cooperation between cardiologists and other healthcare practitioners. She also noted that there was need for improved communication between clinicians, pharmacists and nurses on medication and documentation, adding that everything must be done to please and satisfy the patient who is the king.
Prof. Waleed Al-Habeeb, an association professor of medicine and president of Saudi Heart Failure Group who spoke on the topic: Shifting the Paradigm in Heart Failure equally warned that except new preventive and management strategies are adopted, heart failure will continue to increase, adding that 50 per cent of heart failure patients die within five years of diagnosis.
The Brand Manager of Novartis (Uperio), Olushola Bankole, who spoke before the new product was unveiled noted that while heart failure is now a major public health problem, using Uperio for the management of the condition will help reduce hospitalisation, mortality and cardiovascular death, adding that Uperio is also very cost effective in the long term.